natgillin/translations-raw huggingface dataset:
Examples of symptoms that indicate a low sugar level in the brain: headaches, intense hunger, nausea, vomiting, tiredness, sleepiness, sleep disturbances, restlessness, aggressive behaviour, lapses in concentration, impaired reactions, depression, confusion, speech disturbances (sometimes total loss of speech), visual disorders, trembling, paralysis, tingling sensations (paraesthesia), numbness and tingling sensations in the area of the mouth, dizziness, loss of self-control, inability to look after yourself, convulsions and loss of consciousness.
Primeri simptomov, ki nakazujejo nizek krvni sladkor v možganih so: glavobol, huda lakota, slabost, bruhanje, utrujenost, zaspanost, motnje spanja, nemir, agresivno vedenje, motena koncentracija, poslabšane reakcije, depresija, zmedenost, motnje govora (včasih popolna izguba govora), motnje vida, tresenje, paraliza, mravljinčenje (parestezije), omrtvelost in mravljinčenje v predelu ust, omotica, izguba nadzora nad seboj, nezmožnost poskrbeti zase, krči, izguba zavesti.
Thirst, increased need to urinate, tiredness, dry skin, reddening of the face, loss of appetite, low blood pressure, fast heart beat and glucose and ketone bodies in urine.
Žeja, pogostejše siljenje na vodo, utrujenost, suha koža, pordelost obraza, izguba teka, nizek krvni tlak, hitro bitje srca ter glukoza in ketoni v urinu.
There are no specific data available concerning overdoses with insulin glulisine.
Specifičnih podatkov o prevelikem odmerjanju insulina glulisin ni.
Mild hypoglycaemic episodes can be treated by oral administration of glucose or sugary products.
Blage hipoglikemije je mogoče zdraviti z zaužitjem glukoze ali sladkih izdelkov.
This can quickly cause you to have high blood sugar and diabetic ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar).
To lahko hitro povzroči visok krvni sladkor in diabetično ketoacidozo (kopičenje kisline v krvi, ker telo razgrajuje maščobe namesto sladkorja).
Another phase I study with insulin glulisine and insulin lispro in a non-diabetic population in 80 subjects with a wide range of body mass indices (18-46 kg/m²) has demonstrated that rapid absorption and total exposure is generally maintained across a wide range of body mass indices.
Druga študija faze I, izvedena z insulinom glulisin in insulinom lispro pri skupini 80 oseb brez diabetesa s širokim razponom indeksov telesne mase (18-46 kg/m²) je pokazala, da se hitra absorpcija in celotna izpostavljensot običajno ohranita preko širokega razpona indeksov telesne mase.
While holding the pen with the needle pointing upwards, the insulin reservoir should be tapped gently with the finger so that any air bubbles rise up towards the needle.
Injekcijski peresnik morate prijeti tako, da je igla obrnjena navzgor, in s prstom rahlo potrkati po insulinskem rezervoarju, da se morebitni zračni mehurčki dvignejo proti igli.
Insulin glulisine was rapidly absorbed in both age groups, with similar Tmax and Cmax as in adults (see section 4.2).
tmax in Cmax sta bila podobna kot pri odraslih (glejte poglavje 4.2).
The Apidra cartridges are to be used only in conjunction with the pens: ClikSTAR, Autopen 24, Tactipen, AllStar, AllStar PRO or JuniorSTAR (see section 4.2 and 4.4).
Vložki zdravila Apidra se uporabljajo samo z injekcijskimi peresniki ClikSTAR, Autopen 24, Tactipen, AllStar, AllStar PRO ali JuniorSTAR (glejte poglavji 4.2 in 4.4).
Step 6 Remove and discard the needle
Korak 6 Iglo odstranite in zavrzite
Apidra may be used for Continuous Subcutaneous Insulin Infusion (CSII) in pump systems suitable for insulin infusion with the appropriate catheters and reservoirs.
Continuous Subcutaneous Insulin Infusion) v sistemih s črpalko, primernih za infundiranje insulina z ustreznimi katetri in rezervoarji.
Intravenous bolus administration of insulin glulisine resulted in a higher systemic exposure when compared to subcutaneous injection, with a Cmax approximately 40-fold higher.
V primerjavi s subkutanim injiciranjem je uporaba insulina glulisin v intravenskem bolusu povzročila večjo sistemsko izpostavljenost in Cmax je bila približno 40krat večja.
Insulin glulisine was comparable to insulin lispro for glycaemic control as reflected by changes in glycated haemoglobin (GHb expressed as HbA1c equivalent) from baseline to endpoint and by self-monitored blood glucose values.
Urejenost glikemije je bila med uporabo glulisina primerljiva kot med uporabo lispra, kar se kaže s spremembami v glikiranem hemoglobinu (GHb izražen kot ekvivalent HbA1c) od izhodišča do končne točke in z vrednostmi glukoze v krvi izmerjene s samokontrolo.
In addition, you should have been provided with information about what to do if you become ill or if your blood sugar levels get too high or too low, or if the pump system fails.
Poleg tega vam morajo dati navodila za ravnanje v primeru bolezni ali previsokega ali prenizkega krvnega sladkorja in odpovedi sistema s črpalko.
Insulin glulisine is a recombinant human insulin analogue that is equipotent to regular human insulin.
Insulin glulisin je rekombinanten humani insulinski analog, ekvipotenten navadnemu humanemu insulinu.
Before using SoloStar, the Instructions for use included in the Package leaflet must be read carefully (see section 6.6).
Pred uporabo SoloStarja natančno preberite navodila za ravnanje z injekcijskim peresnikom v navodilu za uporabo (glejte poglavje 6.6).
Apidra vials are for use with insulin syringes with the corresponding unit scale and for use with an insulin pump system (see section 4.2).
Viale zdravila Apidra so namenjene za uporabo z insulinskimi brizgami z ustreznim merilom enot in za uporabo v sistemu z insulinsko črpalko (glejte poglavje 4.2).
Type 1 diabetes mellitus-Adults
Diabetes mellitus tipa 1 - odrasli
The Apidra cartridges are to be used only with the pens: ClikSTAR, Tactipen, Autopen 24, AllStar, AllStar PRO, JuniorSTAR.
Vložki zdravila Apidra so namenjeni samo za uporabo z injekcijskimi peresniki ClikSTAR, Tactipen, Autopen 24, AllStar, AllStar PRO, JuniorSTAR.
Insulin glulisine given 2 minutes (GLULISINE pre) before the start of a meal compared to regular human insulin given 30 minutes (REGULAR 30 min) before the start of the meal (figure 1A) and compared to regular human insulin given 2 minutes (REGULAR pre) before a meal (figure 1B).
Insulin glulisin, uporabljen 2 minuti (GLULISIN - pred) pred začetkom obroka, v primerjavi z navadnim humanim insulinom, uporabljenim 30 minut (NAVADNI - 30 min) pred začetkom obroka (slika 1A), in primerjava z navadnim humanim insulinom, uporabljenim 2 minuti (NAVADNI- pred) pred obrokom (slika 1B).
Apidra vials are for use with insulin syringes with the corresponding unit scale and for use with an insulin pump system.
Viale zdravila Apidra so namenjene za uporabo z insulinskimi brizgami z ustreznim merilom enot in za uporabo v sistemu z insulinsko črpalko.
Examples include: - you have not injected your insulin or not injected enough, or if it has become less effective, for example through incorrect storage, - you are doing less exercise than usual, you are under stress (emotional distress, excitement), or you have an injury, operation, infection or fever, - you are taking or have taken certain other medicines (see section 2, "Other medicines and
Primeri: - insulina niste injicirali, ga niste injicirali dovolj ali je postal manj učinkovit, na primer zaradi nepravilnega shranjevanja, - ste manj dejavni kot ponavadi, ste v stresu (čustvene stiske, vznemirjenost) ali ste poškodovanio, imate operacijo, okužbo ali vročino, - uporabljate ali ste uporabljali določena druga zdravila (glejte poglavje 2, "Druga zdravila in zdravilo Apidra").
Your blood sugar level may either rise or fall if you take: - beta-blockers (used to treat high blood pressure), - clonidine (used to treat high blood pressure), - lithium salts (used to treat psychiatric disorders).
Krvni sladkor se vam lahko zviša ali zniža, če jemljete: zaviralce adrenergičnih receptorjev beta (uporabljajo se za zdravljenje visokega krvnega tlaka), klonidin (uporablja se za zdravljenje visokega krvnega tlaka), litijeve soli (uporabljajo se za zdravljenje psihiatričnih motenj).
Follow your doctor's instructions about the basal infusion rate and the mealtime insulin boluses to be taken.
Upoštevajte zdravnikova navodila o hitrosti bazalne infuzije in bolusih, ki jih morate uporabiti pri obrokih.
The manufacturer's instructions for using the pen must be followed carefully for loading the cartridge, attaching the needle, and administering the insulin injection.
Natančno je treba upoštevati izdelovalčeva navodila za uporabo injekcijskega peresnika, kar zadeva vstavljanje vložka, nameščanje igle in injiciranje insulina.
A 26-week phase III clinical study compared insulin glulisine with insulin lispro both injected subcutaneously shortly (0-15 minutes) before a meal in children (4-5 years: n=9; 6-7 years: n=32 and 8-11 years: n=149) and adolescents (12-17 years: n=382) with type 1 diabetes mellitus using insulin glargine or NPH as basal insulin.
V 26-tedenski klinični študiji III. faze so insulin glulisin in insulin lispro primerjali pri otrocih (4-5 let: n = 9, 6-7 let: n = 32 in 8-11 let: n = 149) in mladostnikih (12-17 let: n = 382) s sladkorno boleznijo tipa 1, ki so kot bazalni insulin uporabljali insulin glargin ali NPH.
Air bubbles must be removed from the cartridge before injection (see instructions for using the pen).
Pred injiciranjem je treba iz vložka odstraniti zračne mehurčke (glejte navodilo za uporabo injekcijskega peresnika).
After intravenous administration, a faster onset and shorter duration of action, as well as a greater peak response were observed as compared with subcutaneous administration.
V primerjavi s subkutano uporabo so po intravenski uporabi ugotovili hitrejši začetek in krajše trajanje delovanja ter večji največji odziv.
The needle should always be removed after each injection and discarded.
Po vsakem injiciranju morate iglo vedno odstraniti in zavreči.
Apidra can be administered intravenously, which should be carried out by healthcare professionals.
Zdravilo Apidra je mogoče dati tudi intravensko, vendar ga sme tako uporabiti samo zdravstveno osebje.
As for all insulins, injection sites and infusion sites within an-injection area (abdomen, thigh or upper arm) must be rotated from one injection to the next.
Tako kot pri vseh insulinih je treba mesta injiciranja in infundiranja na posameznem predelu (trebuh, stegno ali nadlaket) od injekcije do injekcije krožno menjavati.
If your SoloStar is in cool storage, take it out 1 to 2 hours before you inject to allow it to warm up to room temperature.
Če imate SoloStar shranjen na hladnem, ga vzemite iz hladilnika 1 do 2 uri pred injiciranjem, da se ogreje na sobno temperaturo.
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (PRE-FILLED PEN for SoloStar)
PODATKI NA ZUNANJI OVOJNINI ZUNANJA OVOJNINA (Napolnjen injekcijski peresnik za SoloStar)
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS ALUMINIUM FOIL USED FOR SEALING TRANSPARENT PLASTIC TRAY CONTAINING THE CARTRIDGE
BESEDILO, NATISNJENO NA ALUMINIJSKI FOLIJI, UPORABLJENI ZA ZAPRTJE PROSOJNEGA PLASTIČNEGA LEŽIŠČA, V KATEREM JE VLOŽEK
Apidra can be injected in the abdominal wall, the thigh or upper arm or by continuous infusion in the abdominal wall.
Zdravilo Apidra lahko injicirate v trebušno steno, stegno ali nadlaket ali ga dajete s stalno infuzijo v trebušno steno.
It may also be given intravenously by healthcare professionals under close supervision by a doctor.
Zdravilo Apidra je mogoče dati tudi intravensko, vendar ga sme tako uporabiti samo zdravstveno osebje pod strogim nadzorom zdravnika.
Apidra can be administered intravenously.
Zdravilo Apidra je mogoče dati tudi intravensko.
In a study in patients with type 2 diabetes mellitus after subcutaneous administration of 0.2 Units/kg insulin glulisine, the Cmax was 91 µUnits/ml with the interquartile range from 78 to 104 µUnits/ml.
V študiji pri bolnikih z diabetesom mellitusom tipa 2 je bil Cmax po subkutani aplikaciji 0,2 enot/kg insulina glulisin 91 µenot/ml; interkvartilni razpon je bil od 78 do 104 µenot/ml.
QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains 100 Units insulin glulisine (equivalent to 3.49 mg).
KAKOVOSTNA IN KOLIČINSKA SESTAVA En mililiter vsebuje 100 enot insulina glulisin (kar ustreza 3,49 mg).
CLINICAL PARTICULARS
Klinične študije
PARTICULARS TO APPEAR ON THE OUTER PACKAGING OUTER CARTON (10 ml vial)
PODATKI NA ZUNANJI OVOJNINI ZUNANJA OVOJNINA (10 ml viala)
After subcutaneous administration, insulin glulisine is eliminated more rapidly than regular human insulin with an apparent half-life of 42 minutes compared to 86 minutes.
Po subkutani uporabi se insulin glulisin izloča hitreje (navidezni razpolovni čas: 42 minut) kot navadni humani insulin (navidezni razpolovni čas: 86 minut).
Refer to the manufacturer's instructions for using the pen.
Glejte izdelovalčeva navodila za uporabo injekcijskega peresnika.
This medicine contains less than 1 mmol (23 mg) sodium per dose, i.e. it is essentially ‘sodium-free'.
To zdravilo vsebuje manj kot 1 mmol (23 mg) natrija na odmerek, kar pomeni, da je praktično »brez natrija«.
Also contains: metacresol, sodium chloride, trometamol, polysorbate 20, concentrated hydrochloric acid, sodium hydroxide, water for injections (see leaflet for further information).
Vsebuje tudi: metakrezol, natrijev klorid, trometamol, polisorbat 20, koncentrirano klorovodikovo kislino, natrijev hidroksid, vodo za injekcije (za dodatne informacije glejte priloženo navodilo).
Do not use this medicine if it does not appear clear and colourless.
Zdravila Apidra ne uporabljajte, če ni bistro in brezbarvno.
SoloStar is a pre-filled disposable pen containing insulin glulisine.
SoloStar je napolnjen injekcijski peresnik, ki vsebuje insulin glulisin.
In a study in patients with type 1 diabetes mellitus after subcutaneous administration of 0.15 Units/kg, for insulin glulisine the Tmax was 55 minutes and Cmax was 82 ± 1.3 µUnits/ml compared to a Tmax of 82 minutes and a Cmax of 46 ± 1.3 µUnits/ml for regular human insulin.
V študiji pri bolnikih z diabetesom mellitusom tipa 1 sta bila po subkutani uporabi insulina glulisin v odmerku 0,15 enot/kg, tmax 55 minut in Cmax 82 ± 1,3 µenot/ml, po subkutani uporabi navadnega humanega insulina v enakem odmerku pa tmax 82 minut in Cmax 46 ± 1,3 µenot/ml.
A 12-week phase III clinical study performed in patients with type 1 diabetes mellitus receiving insulin glargine as basal therapy indicate that the immediate post-meal administration of insulin glulisine provides efficacy that was comparable to immediate pre-meal insulin glulisine (0-15 minutes) or regular insulin (30-45 minutes).
12-tedenska klinična študija faze III pri bolnikih z diabetesom mellitusom tipa 1, ki so kot bazalno terapijo dobivali insulin glargin, kaže, da apliciranje insulina glulisin takoj po obroku zagotavlja primerljivo učinkovitost kot uporaba insulina glulisin tik (0-15 minut) pred obrokom ali navadnega humanega insulina 30-45 minut pred obrokom.
Apidra should be administered subcutaneously in the abdominal wall, thigh or deltoid or by continuous infusion in the abdominal wall.
Zdravilo Apidra je treba aplicirati subkutano v trebušno steno, stegno ali deltoidni predel ali s stalno infuzijo v trebušno steno.
Your insulin dose may need to be changed during pregnancy and after giving birth.
Med nosečnostjo in po porodu bo morda treba spremeniti odmerek insulina.
Each vial contains 10 ml solution (1000 Units).
Ena viala vsebuje 10 ml raztopine (1000 enot).
Hyperglycaemia can cause diabetic ketoacidosis (build-up of acid in the blood because the body is breaking down fat instead of sugar).
Hiperglikemija lahko povzroči diabetično ketoacidozo (kopičenje kisline v krvi, ker telo za pridobivanje energije razgrajuje maščobe namesto sladkorja).
Subcutaneous or intravenous use
Subkutana ali intravenska uporaba
Insulin glulisine has a more rapid onset of action and a shorter duration of action than regular human insulin.
Insulin glulisin začne delovati hitreje in deluje krajši čas kot navadni humani insulin.
The dose can then be selected.
Potem lahko nastavite odmerek.
If Apidra is mixed with NPH human insulin, Apidra should be drawn into the syringe first.
Če insulin Apidra mešate s humanim insulinom NPH, ga morate v brizgo potegniti prvega.
Instructions for proper use
Navodila za ustrezno ravnanje
Apidra should be used in regimens that include an intermediate or long acting insulin or basal insulin analogue and can be used with oral hypoglycaemic agents.
Zdravilo Apidra je treba uporabljati v shemah, ki vključujejo srednjedolgo- ali dolgodelujoč insulin ali bazalni insulinski analog; zdravilo je mogoče uporabljati tudi s peroralnimi antidiabetiki.
METHOD OF ADMINISTRATION Use specific pens: see leaflet.
POSTOPEK UPORABE Uporabljajte specifične injekcijske peresnike: glejte navodilo za uporabo.
Insulin glulisine shows low plasma protein binding, similar to human insulin.
Vezava insulina glulisin na plazemske proteine je majhna, podobno kot pri humanem insulinu.
Limited pharmacokinetic data are available in elderly patients with diabetes mellitus.
Na voljo so le skopi podatki o farmakokinetiki pri starejših bolnikih z diabetesom mellitusom.
A phase I study in patients with type 1 diabetes mellitus assessed the glucose lowering profiles of insulin glulisine and regular human insulin administered subcutaneously at a dose of 0.15 Units/kg, at different times in relation to a 15-minute standard meal.
Študija faze I pri bolnikih z diabetesom mellitusom tipa 1 je ocenjevala znižanje glukoze z insulinom glulisin in navadnim humanim insulinom, apliciranima subkutano v odmerku 0,15 e./kg ob različnih časih glede na 15-minutni standardni obrok.
The first symptoms which alert you to hypoglycaemia ("warning symptoms") may change, be weaker or may be missing altogether if: - you are elderly, - you have had diabetes for a long time, - you suffer from a certain type of nervous disease (diabetic autonomic neuropathy), - you have recently suffered hypoglycaemia (for example the day before) or if it develops slowly, - you have almost normal or, at least, greatly improved blood sugar levels, - you are taking or have taken certain other medicines (see section 2, "Other medicines and
Prvi simptomi, ki opozarjajo na hipoglikemijo ("opozorilni simptomi"), se lahko spremenijo, oslabijo ali jih celo sploh ni več, če - ste starejši, - imate sladkorno bolezen že dolgo, - imate določeno vrsto okvare živčevja (diabetična avtonomna nevropatija), - ste nedavno (na primer prejšnji dan) doživeli hipoglikemijo ali če se hipoglikemija pojavi počasi, - imate skoraj normalno ali vsaj močno izboljšano koncentracijo krvnega sladkorja, - uporabljate ali ste uporabljali določena druga zdravila (glejte poglavje 2, "Uporaba drugih zdravil").
To prevent any kind of contamination, the reusable pen should be used only by you.
Da preprečite kakršnokoli onesnaženje, smete injekcijski peresnik za večkratno uporabo uporabljati samo vi.
The pharmacokinetic properties of insulin glulisine have not been investigated in patients with decreased liver function.
Farmakokinetične lastnosti insulina glulisin pri bolnikih z zmanjšanim delovanjem jeter niso raziskane.
A 26-week phase III clinical study followed by a 26-week extension safety study was conducted to compare insulin glulisine (0-15 minutes before a meal) with regular human insulin (30-45 minutes before a meal) injected subcutaneously in patients with type 2 diabetes mellitus also using NPH insulin as basal insulin.
26-tedenska klinična študija faze III, kateri je sledila 26-tedenska nadaljevalna študija varnosti, je primerjala insulin glulisin (0-15 minut pred obrokom) z navadnim humanim insulinom (30-45 minut pred obrokom), injiciranima subkutano, in sicer pri bolnikih z diabetesom mellitusom tipa 2, ki so uporabljali tudi insulin NPH kot bazalni insulin.
• Skin and allergic reactions at the injection site Reactions at the injection site may occur (such as reddening, unusually intense pain on injection, itching, hives, swelling or inflammation).
Pojavijo se lahko reakcije na mestu injiciranja (kot so rdečina, neobičajno močna bolečina pri injiciranju, srbenje, koprivnica, oteklina ali vnetje).
Do not put Apidra next to the freezer compartment or a freezer pack.
Zdravila Apidra ne shranjujte v bližini zamrzovalnega razdelka ali zamrzovalnega vložka.
Sanofi-Aventis Deutschland GmbH Industriepark Höchst, D-65926 Frankfurt Germany
Sanofi-Aventis Deutschland GmbH Industriepark Höchst, D-65926 Frankfurt Nemčija
Type 1 diabetes mellitus-Paediatric
Diabetes mellitus tipa 1 - otroci
- If you have missed a dose of Apidra or if you have not injected enough insulin, your blood sugar level may become too high (hyperglycaemia).
- Če ste izpustili odmerek insulina Apidra ali če si niste injicirali dovolj insulina, se lahko koncentracija krvnega sladkorja preveč zviša (hiperglikemija).
Care should be taken to ensure that a blood vessel has not been entered.
Paziti je treba, da zdravilo ne pride v žilo.
Each vial contains 10 ml of solution for injection, equivalent to 1000 Units.
Vsaka viala vsebuje 10 ml raztopine za injiciranje, kar ustreza 1000 enotam.
Apidra 100 Units/ml solution for injection in a vial EU/1/04/285/001-004
Apidra 100 enot/ml raztopina za injiciranje v viali EU/1/04/285/001-004
Apidra in a pre-filled pen is only suitable for injecting just under the skin (see also section 3).
Zdravilo Apidra v napolnjenem injekcijskem peresniku je primerno samo za injiciranje tik pod kožo(glejte tudi poglavje 3).
You may need to talk about - the availability of your insulin in the country you are visiting, - supplies of insulin, injection syringes etc, - correct storage of your insulin while travelling, - timing of meals and insulin administration while travelling, - the possible effects of changing to different time zones, - possible new health risks in the countries to be visited, - what you should do in emergency situations when you feel unwell or become ill.
Med vprašanji, o katerih se boste morali pogovoriti, so - dosegljivost vašega insulina v državi, v katero se odpravljate, - zaloge insulina, injekcijskih brizg itd., - pravilno shranjevanje insulina med potovanjem, - časovni razpored obrokov in dajanje insulina med potovanjem, - možni vplivi spremembe časovnih pasov, - možna nova zdravstvena tveganja v državah, ki jih boste obiskali, - kaj storiti v nujnih primerih, ko se ne počutite dobro ali zbolite.
Apidra SoloStar 100 Units/ml solution for injection in a pre-filled pen EU/1/04/285/029-036
Apidra SoloStar 100 enot/ml raztopina za injiciranje v napolnjenem injekcijskem peresniku EU/1/04/285/029-036
You may need to talk about - the availability of your insulin in the country you are visiting, - supplies of insulin, needles, etc, - correct storage of your insulin while travelling, - timing of meals and insulin administration while travelling, - the possible effects of changing to different time zones, - possible new health risks in the countries to be visited, - what you should do in emergency situations when you feel unwell or become ill.
Med vprašanji, o katerih se boste morali pogovoriti, so - dosegljivost vašega insulina v državi, v katero se odpravljate, - zaloge insulina, igel itd., - pravilno shranjevanje insulina med potovanjem, - časovni razpored obrokov in dajanje insulina med potovanjem, - možni vplivi spremembe časovnih con, - možna nova zdravstvena tveganja v državah, ki jih boste obiskali, - kaj storiti v nujnih primerih, ko se ne počutite dobro ali zbolite.
Injection sites and infusion sites within an injection area (abdomen, thigh or deltoid) should be rotated from one injection to the next.
Mesto injiciranja oz. infundiranja na posameznem predelu (trebuh, stegno, deltoidni predel) je treba od injekcije do injekcije krožno menjati.